Panwen Tian

14PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 14, 2026
Intracranial Efficacy of Crizotinib and Postprogression Therapeutic Strategies in Advanced c-ros Oncogene 1 (ROS1)-Positive Non-Small Cell Lung Cancer (NSCLC), a Multicenter Real-World Study.

|Apr 18, 2026
Granzyme B-based CAR-T cells targeting membrane-bound HSP70 suppress solid tumor growth and metastasis.

|Feb 16, 2026
Breathomics Analysis for Early Diagnosis of Lung Cancer Based on PTR-TOF MS: A Large Sample Size Cross-Sectional Study.

Yan Huang, Wenwen Li, Hanlu Yue

|Dec 15, 2025
A Phase II Study of Sitravatinib Combined With Tislelizumab Plus Docetaxel for Acquired Resistance to PD-(L)1 in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer.

Yalun Li, Jin Zhou, Li Jiang

|Dec 13, 2025
Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients With Advanced NSCLC Who Received Pretreatment With EGFR-TKIs (ML41256): A Multicenter, Prospective, Single-Arm, Phase 2 Trial.

Wenfeng Fang, Jian Fang, Panwen Tian

|Sep 13, 2025
Clinical outcomes for neoadjuvant immunochemotherapy or chemotherapy versus concurrent chemoradiotherapy in limited-stage small-cell lung cancer: A retrospective, multi-center, real-world study.

Zichen Zhao, Hao Rong, Mengxia Li

Pageof 3

Frequent Collaborators

3 joint publications

Yang Xia

2 joint publications

Xudong Zhao

2 joint publications

Dingzhi Huang

2 joint publications

Gen Lin